Target Information
Target General Infomation | Top | ||||
---|---|---|---|---|---|
Target ID |
T90035
|
||||
Target Name |
MERS-CoV spike glycoprotein S2 subunit (S S2)
|
||||
Synonyms |
MERS-CoV S glycoprotein S2 subunit; MERS-CoV E2 S2 subunit; MERS-CoV Peplomer protein S2 subunit
|
||||
Gene Name |
MERS-CoV S
|
||||
Target Status |
Target in Preclinical Study
|
[1] | |||
Disease | [+] 1 Target-related Diseases | + | |||
1 | Middle East Respiratory Syndrome [ICD-11: 1D64] | ||||
Function |
Mediates fusion of the virion and cellular membranes by acting as a class I viral fusion protein. Under the current model, the protein has at least three conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and target cell membrane fusion, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes.
|
||||
BioChemical Class |
Betacoronaviruses spike protein family
|
||||
UniProt ID | |||||
Sequence |
TPSTLTPRSVRSVPGEMRLASIAFNHPIQVDQLNSSYFKLSIPTNFSFGVTQEYIQTTIQ
KVTVDCKQYVCNGFQKCEQLLREYGQFCSKINQALHGANLRQDDSVRNLFASVKSSQSSP IIPGFGGDFNLTLLEPVSISTGSRSARSAIEDLLFDKVTIADPGYMQGYDDCMQQGPASA RDLICAQYVAGYKVLPPLMDVNMEAAYTSSLLGSIAGVGWTAGLSSFAAIPFAQSIFYRL NGVGITQQVLSENQKLIANKFNQALGAMQTGFTTTNEAFRKVQDAVNNNAQALSKLASEL SNTFGAISASIGDIIQRLDVLEQDAQIDRLINGRLTTLNAFVAQQLVRSESAALSAQLAK DKVNECVKAQSKRSGFCGQGTHIVSFVVNAPNGLYFMHVGYYPSNHIEVVSAYGLCDAAN PTNCIAPVNGYFIKTNNTRIVDEWSYTGSSFYAPEPITSLNTKYVAPQVTYQNISTNLPP PLLGNSTGIDFQDELDEFFKNVSTSIPNFGSLTQINTTLLDLTYEMLSLQQVVKALNESY IDLKELGNYTYYNKWPWYIWLGFIAGLVALALCVFFILCCTGCGTNCMGKLKCNRCCDRY EEYDLEPHKVHVH |
Drugs and Modes of Action | Top | ||||
---|---|---|---|---|---|
Preclinical Drugs | [+] 4 Preclinical Drugs | + | |||
1 | HR2P-M2 peptide | Drug Info | Preclinical | MERS | [1] |
2 | HR2P peptide | Drug Info | Preclinical | MERS | [1] |
3 | HR1P peptide | Drug Info | Preclinical | MERS | [1] |
4 | HR2P-M1 peptide | Drug Info | Preclinical | MERS | [1] |
Mode of Action | [+] 1 Modes of Action | + | |||
Inhibitor | [+] 4 Inhibitor drugs | + | |||
1 | HR1P peptide | Drug Info | [1] | ||
2 | HR2P peptide | Drug Info | [1] | ||
3 | HR2P-M1 peptide | Drug Info | [1] | ||
4 | HR2P-M2 peptide | Drug Info | [1] |
References | Top | ||||
---|---|---|---|---|---|
1 | Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat Commun. 2014;5:3067. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.